Capital investments accrued but not yet paid
Alnylam Pharmaceuticals Capital investments accrued but not yet paid increased by 607.6% to $9.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 151.6%, from $3.65M to $9.19M. Over 2 years (FY 2021 to FY 2025), Capital investments accrued but not yet paid shows a downward trend with a -10.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase suggests rising future cash obligations related to capital projects, while a decrease indicates the settlement of these liabilities.
Detailed definition
This metric tracks capital investments or property, plant, and equipment acquisitions that have been recognized as liabi...
Peer comparison
Often found in the supplemental cash flow disclosures or accounts payable notes of capital-intensive firms.
other_capital_expenditures_incurred_but_not_yet_paidHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.51M | -$2.38M | $4.19M | $8.32M | -$1.80M | -$362.00K | $4.03M | $1.63M | -$509.00K | $2.24M | -$1.18M | -$321.00K | $1.58M | $3.65M | $431.00K | $5.52M | $1.30M | $9.19M |
| QoQ Change | — | -152.9% | +275.7% | +98.8% | -121.6% | +79.9% | >999% | -59.6% | -131.2% | +540.5% | -152.6% | +72.8% | +592.8% | +130.7% | -88.2% | >999% | -76.5% | +607.6% |
| YoY Change | — | — | — | — | -139.9% | +84.8% | -51.5% | +190.5% | -40.6% | -44.4% | -172.4% | +36.9% | — | +62.8% | +136.6% | >999% | -18.0% | +151.6% |
Capital investments accrued but not yet paid at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's capital investments accrued but not yet paid?
- Alnylam Pharmaceuticals (ALNY) reported capital investments accrued but not yet paid of $9.19M in Q1 2026.
- How has Alnylam Pharmaceuticals's capital investments accrued but not yet paid changed year-over-year?
- Alnylam Pharmaceuticals's capital investments accrued but not yet paid increased by 151.6% year-over-year, from $3.65M to $9.19M.
- What is the long-term trend for Alnylam Pharmaceuticals's capital investments accrued but not yet paid?
- Over 2 years (2021 to 2025), Alnylam Pharmaceuticals's capital investments accrued but not yet paid has grown at a -10.5% compound annual growth rate (CAGR), from $13.60M to $10.90M.
- What does capital investments accrued but not yet paid mean?
- Capital investments that have been committed or incurred but not yet paid in cash.